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Introduction
In recent years there has been a qualitative change of 
some microbial strains involved in the infectious disease 
pathology, which tend to increase the incidence of mixed 
infections caused by potentially virulent gram-negative and 
gram-positive bacteria and characterized by a marked clini-
cal polymorphism due to a simultaneous exposure of sev-
eral etiological agents, each of which exhibiting a range of 
pathogenicity factors [1].
Microorganisms, involved in mixed infections, com-
monly present antibiotic resistance and a number of patho-
genicity factors, such as lecithinase, haemolytic, antilizo-
zyme, DNA-staining, and adherent activity, etc. [2].
Long-term persistence of bacteria within the host organ-
ism is due to multiple factors that inactivate the antimicro-
bial mechanisms of the immune system. Thus, it is highly 
recommended to study the persistence properties of the mi-
croorganisms in purulent infections, since these are respon-
sible for the elimination rate from the site of inflammation, 
as well as for the prognosis of the disease. It is well known 
that the bacterial persistent potential is dependent upon the 
length of pathogenic harboring within the macro-organism, 
whereas its suppression via drugs may weaken this infec-
tious potential [3-7].
The studies, conducted across different countries, have 
revealed a range of species isolated from trophic ulcers and 
their antimicrobial resistance, as well as the incidence of 
multidrug resistance (MDR) cases, strains of methicillin-
resistant Staphylococcus spp. (MRS) and extended-spectrum 
beta-lactamases (ESBL), thus, suggesting that administra-
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Abstract
Background: Recently, a particular attention has been drawn to the study of the microbial persistence properties and their correlation with the rate of 
elimination from the source of infection, as well as the prognosis of the disease progression.
Material and methods: There were examined 44 samples taken from patients with trophic ulcers. The bacteriological examination, as well as tests on 
determining both the persistence factors and the antibiotic susceptibility of the isolated strains were carried out according to the current method.
Results: There were determined 80 isolated bacterial strains. Two and more strains were isolated in over half of these cases (52.3%). The most commonly 
involved strains were the genus Staphylococcus, followed by Enterobacter spp., Pseudomonas spp., Candida spp., and enterococci. Both gram-negative 
and gram-positive species exhibited a high-level antimicrobial resistance. The study of the persistence factors revealed that the strains isolated in mixed 
culture showed a higher rate of virulence (1.0-1.5 times higher) compared to isolates in pure culture.
Conclusions: The main bacterial strains isolated from trophic ulcers are the genus Staphylococcus and the Enterobacteriaceae family. Isolated strains 
showed higher level of antimicrobial resistance and multiple persistence factors. The study results proved that treatment of trophic ulcers is still a major 
problem, requiring rational monitoring and management strategies.
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tion of empirical antimicrobial therapy might increase the 
rate of a treatment failure [8-10].
Treatment of trophic ulcer is a challenging task for clini-
cians and remains a current and relevant issue [11].
As regarding to the aforementioned, the purpose of the 
study was to determine the spectrum of bacteria isolated 
from trophic ulcers, to study the antibiotic susceptibility of 
the bacterial strains and to determine their hemolytic, leci-
thinase, anti-lysozyme, and anti-complementary properties, 
as well as to prove their diagnostic importance in detection 
of the bacterial targets in order to select the appropriate 
drug therapy.
Material and methods
Studies were conducted on 80 microbial strains isolated 
from trophic ulcers. The microbiological investigations, as 
well as the persistence factors and antibiotic sensitivity as-
sessment of the isolated strains were performed within the 
microbiological laboratory of the National Agency for Pub-
lic Health. The bacterial strains were isolated and detected 
according to the methodology described in “Basic labora-
tory procedures in clinical bacteriology”. Antibiotic suscep-
tibility was tested by Vitek 2 compact and Kirby-Bauer disk 
diffusion method. Antibiotic susceptibility testing and data 
interpretation have been standardized, in accordance with 
European Committee on Antimicrobial Susceptibility Test-
ing (EUCAST) guidelines for current antibiotic assessment 
[12]. Antibiotic disk diffusion testing included: cefoxitin (30 
mg), erythromycin (15 mg), clindamycin (2 mg), gentami-
cin (10 mg), cefepime (30 mg), ceftazidime (10 mg) , me-
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ropenem (10 mg), aztreonam (30 mg), ciprofloxacin (5 mg), 
linezolid (10 mg), tetracycline (30 mg), amikacin (30 mg), 
chloramphenicol (30 mg), rifampicin (5 mg), ampicillin (10 
mg). Strains that showed resistance to three or more antibi-
otic groups were considered polyresistant [13].
The persistence factors were determined in the most 
common isolates from trophic ulcers. The lecithinase ac-
tivity was assayed on the egg yolk salt agar, the hemolytic 
activity on a blood agar plate and the anti-lysozyme and an-
ti-complementary activity we determined according to the 
method described by Bukharin O. et al. [14-16].
Staphylococcus aureus (ATCC 25923), Escherichia coli 
(ATCC-25922) and Pseudomonas aeruginosa (ATCC-
27853) reference strains were used for quality control. Sta-
tistical data analysis was carried out via EpiInfo 2000.
Ethical Issues
The strains used in this study were obtained from the 
routine analysis of clinical specimens. Sample collection did 
not involve direct contact with the patient, thus no consent 
was required. The study was conducted and approved by the 
Ethics Committee no. 65 / 12.04.2017 of Nicolae Testemi-
tanu State University of Medicine and Pharmacy from the 
Republic of Moldova.
Results
The bacteriological study was conducted on 44 samples 
collected from patients with trophic ulcers. A single bacte-
rial strain was isolated in 36.3% of cases, two and more spe-
cies – in 52.3% and no strains – in 11.4% of cases.
A total of 80 bacterial species were isolated and identi-
fied. The most common strains, isolated from trophic ul-
cers, were the Staphylococcus (predominantly S. aureus), 
then enterobacteria (Klebsiella spp., Enterobacter spp., Pro-
teus spp., Serratia spp., Escherichia spp.), non-fermenting 
bacilli Pseudomonas spp., levuriform fungi of Candida type 
and enterococci. (fig. 1).
Fig. 1.  The etiological spectrum of microorganisms isolated 
from trophic ulcers.
Among the infections caused by a single strain, the most 
common was found Staphylococcus aureus (43.75%), along 
with the other isolates such as Pseudomonas aeruginosa 
(18.75%), Staphylococcus haemolyticus (12.5%), Proteus mi-
rabilis (12.5%), Klebsiella pneumoniae and Enterobacter ger-
goviae (6.25%).
S. aureus was determined in 82.6% of mixed infections, 
whereas 30.4% of cases were associated with Klebsiella and 
Pseudomonas species. Two-strain associations were record-
ed in 52.2% of cases, three-strain in 13.1%, 4 and 5 species 
were found in 13.1% and 4.3% of cases, respectively.
Staphylococcus spp. strains showed a marked sensitivity 
to vancomycin (96.4%) and only 1 strain showed interme-
diate resistance to vancomycin, tetracycline (89.3%) and 
linezolid (82.1%). Of the 28 tested staphylococcus strains, 
13 (46.4%) were methicillin-resistant (MRS). MRS strains 
were more sensitive to vancomycin (100%), tetracycline 
(84.6%) and linezolid (76.9%), followed by chlorampheni-
col (79.2%), whereas a reduced sensitivity was recorded to 
erythromycin (27.5%) and ciprofloxacin (17.3%). More-
over, the obtained data highlighted a number of strains with 
multiple antibiotic resistance and only 3 (10.7%) of the 28 
strains were sensitive to all the tested antibiotics.
Carbapenems were found to be the most effective an-
tibacterial drugs (86.1%) in treatment of enterobacterial 
infections; however, the bacteria exhibited a marked re-
sistance to aminoglycosides (> 70%), fluorquinolones and 
cephalosporins (> 80%).
Furthermore, this study detected 15 extended-spectrum 
beta-lactamase strains (BLSE), which showed susceptibil-
ity to meropenem (86.6%), followed by amikacin (60.0%), 
gentamicin (53.3%), ceftazidime (26.6% ) and ciprofloxacin 
(13.3%).
The bacterial strains of Pseudomonas genus presented 
susceptibility rates to aminoglycosides (100%) and mono-
bactam drugs (90%) and resistance to fluoroquinolones 
(100%), carbapenems (90%) and cephalosporins (80%).
Levuriform fungi of the genus Candida isolated from 
trophic ulcers made up 7.5%. In the present study, 66.7% of 
Candida spp. were susceptible to fluconazole, 100% to am-
photericin B, 83.3% and 50.0% to voriconazole and itracon-
azole, respectively.
In the next step of our study, we determined the levels of 
expression for some persistence factors found in the most 
common bacterial strains, isolated from trophic ulcers.
The study of the persistence factors of bacteria isolated 
from trophic ulcers showed a higher- level expression in 
strains isolated from mixed infections (1.0-1.5 times) com-
pared to those isolated in pure culture.
Lecithinase was among the studied persistence factors. 
This enzyme destroys lecithin and releases the receptors 
with which microorganisms interact [16]. Of the total 26 S. 
aureus strains, 24 (92.3%) showed lecithinase activity and 2 
(7.6%) strains were inactive.
Hemolysin was determined as another persistent factor, 
leading to development of chronic infectious disease. He-
molytic activity was detected in 38 (47.5%) bacterial strains 
isolated from trophic ulcers. A higher level of expression 
was also recorded in strains isolated from the mixed infec-
tions, compared to those isolated in pure culture.
Lysozyme is a carbohydrase that selectively breaks down 
the glycosidic bonds between N-acetylmuramic acid and N-
acetylglucosamine and is a component of the peptidogly-
can cell wall. If the peptidoglycan network is destroyed, the 
osmotic pressure between the inside and the outside of the 
cell is no longer balanced and thus is being destroyed [17]. 
Therefore, an important strategy of the bacteria is to protect 
themselves against this enzyme, aiming to survive longer 
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in the host organism. Of 26 strains of S. aureus, 14 (53.8%) 
strains showed antilysozyme activity and 12 (46.2%) were 
inactive. The antilysozyme activity was assessed by lyso-
zyme titres in the medium, which revealed that out of 14 
Staphylococcus aureus strains,  5 (35.7%) strains showed a 
lysozyme concentration greater than 10 µg/ml, 6 (42.9%)  – 
a concentration of 5-10 µg/ml and 3 (21.4%) – 5 µg/ml.
The antilysozyme activity of Enterobacteriaceae strains 
was also assessed, showing that of 36 strains, 24 (66.7%) 
strains exhibited an antilysozyme activity, of which 6 
(25.0%) in concentration greater than 10 µg/ml, 8 (33.3%) 
– in concentration from 5-10 µg / ml, 10 (41.7%) – in con-
centration of 5 µg/ml and 12 (33.3%) strains did not present 
any activity (р <0.05).
Another important factor that provides persistence for 
the microorganisms within the infection site is the ability 
of the bacterial cells to inactivate the complement system of 
the macroorganism [16] . The study of the anti-complement 
activity of the strains isolated in pure culture showed that 
62.5% of the strains inactivate the complement and 37.5% of 
the strains did not present anti-complement activity.
Of the 26 Staphylococcus aureus strains, 24 strains 
(92.3%) exhibited complementary activity, of which 7 
(29.2%) strains inactivated the complement at a concentra-
tion of 5 CH50/ml, 3 (12.5%) – at concentration from 5 – 15 
CH50/ml and 35 (58.3%) in a concentration greater than 
15 CH50/ml. Only two strains did not exhibit anti-comple-
ment activity (7.7%).
Anticomplementary activity is a common feature among 
the bacteria of the Enterobacteriaceae family. 34 (94.4%) 
strains of enterobacteria out of 36 isolates from trophic ul-
cers showed anti-complementary activity. 1 (2.9%) strain 
inactivated the complement at a concentration of 5 CH50/
ml, 6 (17.6%) at a concentration from 5-15 CH50/ml and 27 
(79.4%) strains at a concentration greater than 15 CH50/ml.
The data study of the anti-complementary activities in 
monocultures compared to isolated cultures in associations 
(co-culture isolates) showed that the latter are often related 
to medium and high anti-complementary activity (p<0.05).
Conclusions
1. The study of the spectrum of microorganisms isolated 
from trophic ulcers has revealed the significant role of strains 
belonging to the genus Staphylococcus, followed by entero-
bacteria, Pseudomonas spp., levuriform fungi of the genus 
Candida and streptococci. Staphylococcus aureus strain was 
predominantly isolated in both pure and mixed cultures.
2. Both gram-positive and gram-negative strains isolat-
ed from trophic ulcers showed a marked resistance to the 
antimicrobial drugs tested.
3. The study of the persistence factors confirmed that 
the strains isolated from trophic ulcers exhibit a range of 
properties to inactivate the natural resistance factors of the 
macroorganism. 
4. It is essential to understand the pathogenic persistence 
factors, since it might provide effective targeted therapies 
for controlling the microbial growth in trophic ulcers.
5. The study results have proved that treatment of tro-
phic ulcers is still a major medical concern, requiring cur-
rent management strategies.
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